購物比價 | 找書網 | 找車網 |
FindBook |
有 1 項符合
Clinical Trial Data Analysis Using R and SAS, Second Edition的圖書 |
Clinical Trial Data Analysis Using R and SAS 作者:Ding-Geng(Din)Chen,Karl E. Peace,Pinggao Zhang 出版社:CRC Press 出版日期:2017-06-01 語言:英文 |
圖書館借閱 |
國家圖書館 | 全國圖書書目資訊網 | 國立公共資訊圖書館 | 電子書服務平台 | MetaCat 跨館整合查詢 |
臺北市立圖書館 | 新北市立圖書館 | 基隆市公共圖書館 | 桃園市立圖書館 | 新竹縣公共圖書館 |
苗栗縣立圖書館 | 臺中市立圖書館 | 彰化縣公共圖書館 | 南投縣文化局 | 雲林縣公共圖書館 |
嘉義縣圖書館 | 臺南市立圖書館 | 高雄市立圖書館 | 屏東縣公共圖書館 | 宜蘭縣公共圖書館 |
花蓮縣文化局 | 臺東縣文化處 |
|
Review of the First Edition
"The goal of this book, as stated by the authors, is to fill the knowledge gap that exists between developed statistical methods and the applications of these methods. Overall, this book achieves the goal successfully and does a nice job. I would highly recommend it …The example-based approach is easy to follow and makes the book a very helpful desktop reference for many biostatistics methods."
—Journal of Statistical Software
Clinical Trial Data Analysis Using R and SAS, Second Edition provides a thorough presentation of biostatistical analyses of clinical trial data with step-by-step implementations using R and SAS. The book’s practical, detailed approach draws on the authors’ 30 years’ experience in biostatistical research and clinical development. The authors develop step-by-step analysis code using appropriate R packages and functions and SAS PROCS, which enables readers to gain an understanding of the analysis methods and R and SAS implementation so that they can use these two popular software packages to analyze their own clinical trial data.
What’s New in the Second Edition
Adds SAS programs along with the R programs for clinical trial data analysis.
Updates all the statistical analysis with updated R packages.
Includes correlated data analysis with multivariate analysis of variance.
Applies R and SAS to clinical trial data from hypertension, duodenal ulcer, beta blockers, familial andenomatous polyposis, and breast cancer trials.
Covers the biostatistical aspects of various clinical trials, including treatment comparisons, time-to-event endpoints, longitudinal clinical trials, and bioequivalence trials.
|